-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
DTRT Health Acquisition Corp. (NASDAQ:DTRT) Sees Large Drop in Short Interest
DTRT Health Acquisition Corp. (NASDAQ:DTRT) Sees Large Drop in Short Interest
DTRT Health Acquisition Corp. (NASDAQ:DTRT – Get Rating) saw a large decline in short interest during the month of November. As of November 30th, there was short interest totalling 10,400 shares, a decline of 31.6% from the November 15th total of 15,200 shares. Based on an average daily volume of 82,400 shares, the short-interest ratio is presently 0.1 days.
Hedge Funds Weigh In On DTRT Health Acquisition
Hedge funds have recently made changes to their positions in the business. Captrust Financial Advisors acquired a new position in shares of DTRT Health Acquisition in the 1st quarter worth approximately $48,000. UBS Group AG increased its position in shares of DTRT Health Acquisition by 1,627.2% in the second quarter. UBS Group AG now owns 8,688 shares of the company's stock worth $87,000 after acquiring an additional 8,185 shares in the last quarter. Landscape Capital Management L.L.C. purchased a new position in shares of DTRT Health Acquisition in the third quarter worth approximately $106,000. Goldman Sachs Group Inc. purchased a new position in shares of DTRT Health Acquisition in the first quarter worth approximately $140,000. Finally, Royal Bank of Canada increased its position in shares of DTRT Health Acquisition by 215.0% in the first quarter. Royal Bank of Canada now owns 16,190 shares of the company's stock worth $162,000 after acquiring an additional 11,050 shares in the last quarter. Institutional investors and hedge funds own 64.50% of the company's stock.
Get DTRT Health Acquisition alerts:DTRT Health Acquisition Stock Performance
Shares of DTRT traded up $0.08 during mid-day trading on Wednesday, hitting $10.28. The company's stock had a trading volume of 443,585 shares, compared to its average volume of 79,807. The firm has a 50-day moving average price of $10.23 and a 200 day moving average price of $10.14. DTRT Health Acquisition has a fifty-two week low of $9.90 and a fifty-two week high of $11.34.
About DTRT Health Acquisition
(Get Rating)DTRT Health Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other similar business combination with one or more operating businesses or assets. The company was incorporated in 2021 and is based in Oak Brook, Illinois.
Featured Stories
- Get a free copy of the StockNews.com research report on DTRT Health Acquisition (DTRT)
- REV Group Leads Specialty Vehicle Manufacturers Higher
- NVIDIA vs AMD: Which is better for 2023?
- Can FDA Approval Bolster DexCom, Inc.?
- Harpoon Therapeutics Remains Volatile After Promising News
- Will Nordstrom Stock be the Grinch This Year?
Receive News & Ratings for DTRT Health Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DTRT Health Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
DTRT Health Acquisition Corp. (NASDAQ:DTRT – Get Rating) saw a large decline in short interest during the month of November. As of November 30th, there was short interest totalling 10,400 shares, a decline of 31.6% from the November 15th total of 15,200 shares. Based on an average daily volume of 82,400 shares, the short-interest ratio is presently 0.1 days.
纳斯达克健康收购公司(DTRT-GET Rating)看到空头股数在11月份出现了大幅下滑。截至11月30日,空头股数共有10,400股,较11月15日的15,200股下降了31.6%。以日均成交量82,400股计算,目前短息比率为0.1天。
Hedge Funds Weigh In On DTRT Health Acquisition
对冲基金参与DTRT Health收购
Hedge funds have recently made changes to their positions in the business. Captrust Financial Advisors acquired a new position in shares of DTRT Health Acquisition in the 1st quarter worth approximately $48,000. UBS Group AG increased its position in shares of DTRT Health Acquisition by 1,627.2% in the second quarter. UBS Group AG now owns 8,688 shares of the company's stock worth $87,000 after acquiring an additional 8,185 shares in the last quarter. Landscape Capital Management L.L.C. purchased a new position in shares of DTRT Health Acquisition in the third quarter worth approximately $106,000. Goldman Sachs Group Inc. purchased a new position in shares of DTRT Health Acquisition in the first quarter worth approximately $140,000. Finally, Royal Bank of Canada increased its position in shares of DTRT Health Acquisition by 215.0% in the first quarter. Royal Bank of Canada now owns 16,190 shares of the company's stock worth $162,000 after acquiring an additional 11,050 shares in the last quarter. Institutional investors and hedge funds own 64.50% of the company's stock.
对冲基金最近对其在该业务中的头寸进行了调整。CapTrust Financial Advisors在第一季度收购了DTRT Health收购公司的新股票,价值约4.8万美元。瑞银集团第二季度增持DTRT Health收购股份1,627.2%。瑞银集团(UBS Group AG)在上个季度增持了8,185股瑞银股票后,目前持有8,688股该公司股票,价值87,000美元。景观资本管理公司在第三季度购买了DTRT Health收购的新头寸,价值约10.6万美元。高盛股份有限公司在第一季度购买了DTRT Health收购的新头寸,价值约140,000美元。最后,加拿大皇家银行在第一季度增持了DTRT Health收购的股份215.0。加拿大皇家银行在上个季度增持了11,050股后,现在持有该公司16,190股股票,价值162,000美元。机构投资者和对冲基金持有该公司64.50%的股票。
DTRT Health Acquisition Stock Performance
DTRT Health Acquisition股票表现
Shares of DTRT traded up $0.08 during mid-day trading on Wednesday, hitting $10.28. The company's stock had a trading volume of 443,585 shares, compared to its average volume of 79,807. The firm has a 50-day moving average price of $10.23 and a 200 day moving average price of $10.14. DTRT Health Acquisition has a fifty-two week low of $9.90 and a fifty-two week high of $11.34.
在周三午盘交易中,DTRT的股价上涨0.08美元,达到10.28美元。该公司股票的成交量为445,585股,而其平均成交量为79,807股。该公司的50日移动均线价格为10.23美元,200日移动均线价格为10.14美元。DTRT Health Acquisition的收购价为9.90美元,为52周低点,52周高点为11.34美元。
About DTRT Health Acquisition
关于DTRT Health Acquisition
DTRT Health Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other similar business combination with one or more operating businesses or assets. The company was incorporated in 2021 and is based in Oak Brook, Illinois.
DTRT Health Acquisition Corp.没有重大业务。拟与一家或多家经营性企业或资产进行合并、资本换股、资产收购、股票购买、重组或其他类似的业务合并。该公司成立于2021年,总部设在伊利诺伊州的奥克布鲁克。
Featured Stories
专题报道
- Get a free copy of the StockNews.com research report on DTRT Health Acquisition (DTRT)
- REV Group Leads Specialty Vehicle Manufacturers Higher
- NVIDIA vs AMD: Which is better for 2023?
- Can FDA Approval Bolster DexCom, Inc.?
- Harpoon Therapeutics Remains Volatile After Promising News
- Will Nordstrom Stock be the Grinch This Year?
- 免费获取StockNews.com关于DTRT健康获取(DTRT)的研究报告
- REV集团引领专用车制造商走高
- NVIDIA VS AMD:2023年哪一种更好?
- FDA的批准能支持DexCom,Inc.吗?
- 鱼叉治疗公司在有希望的消息传出后仍不稳定
- 诺德斯特龙股票公司会成为今年的格林奇吗?
Receive News & Ratings for DTRT Health Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DTRT Health Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
接受每日DTRT健康获取的新闻和评级-在下面输入您的电子邮件地址,以通过MarketBeat.com的免费每日电子邮件时事通讯接收对DTRT Health Acquisition和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧